| Literature DB >> 29137620 |
Xiangyu Mou1,2, Edward J Spinard1, Shelby L Hillman1, David R Nelson3.
Abstract
BACKGROUND: Vibrio anguillarum is an extracellular bacterial pathogen that is a causative agent of vibriosis in finfish and crustaceans with mortality rates ranging from 30% to 100%. Mutations in central metabolism (glycolysis and the TCA cycle) of intracellular pathogens often result in attenuated virulence due to depletion of required metabolic intermediates; however, it was not known whether mutations in central metabolism would affect virulence in an extracellular pathogen such as V. anguillarum.Entities:
Keywords: Hemolysin; Isocitrate dehydrogenase; TCA cycle; Vibrio anguillarum; Vibriosis; Virulence
Mesh:
Substances:
Year: 2017 PMID: 29137620 PMCID: PMC5686843 DOI: 10.1186/s12866-017-1124-1
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Bacterial strains and plasmids used in this study
| Strain or plasmid | Description | Reference |
|---|---|---|
|
| ||
| M93Sm | Spontaneous Smr mutant of M93 (serotype O2a) | [ |
| XM420 | Smr Cmr; | This study |
| ES422 | Smr; Restored | This study |
| XM440 | Smr Cmr; | This study |
| XM450 | Smr Cmr; | This study |
| XM460 | Smr Cmr; | This study |
| XM470 | Smr Cmr; | This study |
| XM410 | Smr Cmr; | This study |
| XM430 | Smr Cmr; | This study |
|
| ||
| SM10 |
| [ |
| S100 | Kmr; Sm10 containing plasmid pNQ705–1 | [ |
| Q420 | Kmr Cmr; Sm10 containing plasmid pNQ705- | This study |
| Q440 | Kmr Cmr; Sm10 containing plasmid pNQ705- | This study |
| Q450 | Kmr Cmr; Sm10 containing plasmid pNQ705- | This study |
| Q460 | Kmr Cmr; Sm10 containing plasmid pNQ705- | This study |
| Q470 | Kmr Cmr; Sm10 containing plasmid pNQ705- | This study |
| Q410 | Kmr Cmr; Sm10 containing plasmid pNQ705- | This study |
| Q430 | Kmr Cmr; Sm10 containing plasmid pNQ705- | This study |
| Plasmid | ||
| pNQ705–1 | Cmr; suicide vector with R6K origin | [ |
| pNQ705- | Cmr; For | This study |
| pNQ705- | Cmr; For | This study |
| pNQ705- | Cmr; For | This study |
| pNQ705 | Cmr; For | This study |
| pNQ705- | Cmr; For | This study |
| pNQ705 | Cmr; For | This study |
| pNQ705- | Cmr; For | This study |
Primers used in this study
| Primer | Sequence (5′ to 3′, underlined sequences are designed restriction sites) | Description | Reference |
|---|---|---|---|
| pr31 | GGT | For | This study |
| pr32 | AAA | For | This study |
| pr50 | AAA | For | This study |
| pr51 | GGT | For | This study |
| pr52 | AAA | For | This study |
| pr53 | GGT | For | This study |
| pr54 | AAA | For | This study |
| pr55 | GGT | For | This study |
| pr56 | GGT | For | This study |
| pr57 | GGG | For | This study |
| pr29 | GGT | For | This study |
| pr30 | AAA | For | This study |
| pr33 | AAA | For | This study |
| pr34 | AAA | For | This study |
| vah1 F RT | GTTTGGTATGGAACACCGCTCAAG | For | This study |
| vah1 R RT | GGCTCAACCTCTCCTTGTAACCAA | For | This study |
| plp F RT | CAGACGACCACCAGTAACCACTAA | For | [ |
| plp R RT | GCAATCATGATGACCCAGCAACAG | For | [ |
| Pm111 | GGAAATTATTCCGCCGACGATGGA | For | [ |
| Pm112 | GCCGATACCGTATCGTTACCTGAA | For | [ |
Fig. 1Embden-Meyerhoff-Parnas Pathway, TCA cycle, and metabolism of fructose. The arrows indicate the physiological directions of the reactions. The gene symbols of the enzyme for each reaction are listed beside the reaction. Boxed genes indicate the genes that were mutated in this study (Table 1)
Metabolism genes examined in this study
| Gene or operon | Product | Present in sequenced |
|---|---|---|
|
| Type II citrate synthase | Yes |
|
| Aconitate hydratase B | Yes |
|
| Isocitrate dehydrogenase | Yes |
|
| 2-oxoglutarate dehydrogenase | Yes |
|
| Succinyl-CoA synthetase | Yes |
|
| Succinate dehydrogenase | Yes |
|
| Fumarate reductase | Yes |
|
| Aerobic fumarate hydratase (class I, class II) |
|
|
| Anaerobic fumarate hydratase (class I) | Not found |
|
| Malate dehydrogenase | Yes |
|
| Fructose repressor protein | Yes |
a V. anguillarum strains: M93Sm, 775, 96F, M3, NB10, RV22, 90-11-286
Fig. 2Percent survival of rainbow trout IP injected with V. anguillarum wild type (M93Sm) and various mutant strains at a dosage of a 2 × 105 CFU/fish and b 4 × 105 CFU/fish. Negative control groups of fish (Mock) were injected with sterile NSS. Five fish were used for each treatment. (One fish treated with the sucA mutant died, but not from vibriosis and no V. anguillarum were recovered, so only four fish were counted). *Statistically significant difference compared to M93Sm (p < 0.05)
Fig. 3Percent survival of rainbow trout infected by immersion with V. anguillarum strains M93Sm (wild type) or XM420 (icd) at a dose of 4 × 106 CFU/ml. A negative control group of fish (Mock) was immersed in sterile NSS. Ten fish were used for each treatment. *Statistically significant difference compared to M93Sm (p < 0.05)
Fig. 4Percent survival of immersion vaccinated rainbow trout. Rainbow trout were sham vaccinated with NSS (labeled as “untreated”) or immersed vaccinated with the icd mutant (Labeled as “treated with icd”) and challenged with wild type V. anguillarum M93Sm (4 × 106 CFU/ml). Five fish were used for each treatment. *Statistically significant difference compared to M93Sm (p < 0.05)
Fig. 5Relative expression of vah1, plp, rtxA determined by qRT-PCR analysis of V. anguillarum wild-type (M93Sm) and various TCA mutants during logarithmic (Log)-phase growth. The data presented are representative of two independent experiments. Each value is the average for three replicates. Between marked strains and M93Sm: * p < 0.05 and *** p < 0.001. Error bars represent 1 standard deviation
Fig. 6Growth curves of various V. anguillarum strains grown in LB20 at 27 °C with shaking (200 rpm). At various time points after inoculation samples were taken for determination of optical density at 600 nm (OD600). The data are from one representative experiment
Generation times of various V. anguillarum strains grown in LB20a
| Strain | Exponential Phase I | Exponential Phase II |
|---|---|---|
| M93Sm | 44.00 | NA |
|
| 54.95 | NA |
|
| 64.32 | 98.52 |
|
| 52.42 | 99.57 |
|
| 61.19 | 101.70 |
|
| 73.55 | 89.38 |
|
| 67.11 | 115.28 |
|
| 58.59 | NA |
NA not applicable
aValues calculated from data presented in Fig. 6 during exponential growth
Final cell density (CFU/ml) of various V. anguillarum cultures grown for 24 h
| Strain | CFU/ml in LB20 | CFU/ml in NSSM (200 μg/ml) |
|---|---|---|
| M93Sm | 3.4 × 109 (±0.3 × 109) | 4.2 × 109 (±0.7 × 109) |
|
| 1.6 × 109 (±0.02 × 109)* | 1.3 × 109(±0.3 × 109)* |
*Statistically significant difference compared to M93Sm (p < 0.05)
Fig. 7Growth of V. anguillarum WT (M93Sm) and the icd mutant under various conditions. a Final cell densities (OD600) of V. anguillarum strains after 24 h of growth in 3M plus 0.15% glucose supplemented with or without 5.9 mM glutamate. b Growth curves of V. anguillarum M93Sm (black) and the icd mutant (blue) in LB20 (dashed lines) or LB20 supplemented with 118 mM glutamate (solid lines). Statistical analysis was based on data at 24 h. c Final cell densities (OD600) of V. anguillarum M93Sm and icd mutant strains grown in LB20 supplemented with decreasing amounts of glutamate. In each experiment cells grown overnight in LB20 were washed in NSS and used to inoculate the appropriate media. Cultures were incubated at 27 °C in a shaking water bath (200 rpm) and at various time points after inoculation samples were taken for determination of optical density at 600 nm (OD600). Different letters indicate statistical significance among groups (p < 0.05). Error bars represent 1 standard deviation
Fig. 8Percent survival of rainbow trout immersed with various V. anguillarum strains at a dosage of 4 × 106 to 7 × 106 CFU/ml. Five fish were used for the uninfected (mock) group. Fifteen fish were treated with the restored icd strain. Nineteen fish were treated with M93Sm and twenty fish were treated with the icd mutant. *Statistically significant difference compared to M93Sm (p < 0.01)